A dual altered peptide ligand down-regulates myasthenogenic T cell responses and reverses experimental autoimmune myasthenia gravis via up-regulation of Fas–FasL-mediated apoptosis

Documenti analoghi

• A 50-kDa ERK-like protein is up-regulated by a dual altered peptide ligand that suppresses myasthenia gravis-associated responses
  di: Ben-David, Hava, et al.
  Pubblicazione: (2006)
• Oral administration of a dual analog of two myasthenogenic T cell epitopes down-regulates experimental autoimmune myasthenia gravis in mice
  di: Paas-Rozner, Miri, et al.
  Pubblicazione: (2000)
• Suppression of myasthenogenic responses of a T cell line by a dual altered peptide ligand by induction of CD4(+)CD25(+) regulatory cells
  di: Aruna, Badiga Venkata, et al.
  Pubblicazione: (2005)
• Down-regulation of myasthenogenic T cell responses by a dual altered peptide ligand via CD4(+)CD25(+)-regulated events leading to apoptosis
  di: Ben-David, Hava, et al.
  Pubblicazione: (2005)
• A dual altered peptide ligand down-regulates myasthenogenic T cell responses by up-regulating CD25- and CTLA-4-expressing CD4(+) T cells
  di: Paas-Rozner, Miri, et al.
  Pubblicazione: (2003)